About | Free Trial

Last Update

2016-06-27T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Bruce Weintraub?

Dr. Bruce Weintraub D.

President, Chief Executive Officer and Cofounder

Trophogen Inc

Direct Phone: (301) ***-****       

Email: b***@***.com

Trophogen Inc

9714 Medical Center Dr., Suite 1114

Rockville, Maryland 20850

United States

Company Description

Established in July 2001 by Toucan Capital, Trophogen is a start-up biotechnology company based in Rockville, Maryland. Trophogen was formed by two molecular endocrinologists who spent numerous years as academicians at NIH and the University of Maryland b... more

Find other employees at this company (4)

Background Information

Education

BA

MDfrom Harvard University

BA

Princeton University

MD

Web References (44 Total References)


Bruce ...

www.mentorhealth.com [cached]

Bruce Weintraub President and CEO, Trophogen

Dr. Weintraub has more than 30 years experience in a biomedical research career that has focused on molecular, cellular, clinical and therapeutic aspects of glycoprotein hormones, related growth factors, thyroid hormone and their receptors. He is the author of over 300 scientific papers, reviews and book chapters. In addition has several issued and pending patents related to the cloning of the human TSH beta subunit, development of recombinant TSH, and development of superactive analogs of TSH, gonadotropins and related cystine knot growth factors.
He is well known for his basic science work related to pituitary and recombinant TSH synthesis, glycosylation and action, affinity chromatography as well as clinical aspects of syndromes of inappropriate TSH secretion. In addition he was among the first to recognize and define the clinical and molecular aspects of thyroid hormone resistance, TSH- producing pituitary tumors and ectopic production of placental hormones and free subunits by various tumors. He is particularly recognized for his role as coinventor, codeveloper and a leading investigator in the international clinical trials of recombinant TSH, approved by the FDA in 1998 for the diagnosis of thyroid cancer, which has revolutionized the approach world -wide to that disease.


Advanced Bioscience Laboratories

www.ablinc.com [cached]

"Trophogen is very pleased that the lead product of its large portfolio of more potent/efficacious and longer acting human and bovine recombinant superagonist analogs will be commercialized with ABL's expert assistance," said Dr. Bruce Weintraub, President and COO of Trophogen.


Dr. Bruce Weintraub, ...

www.kipling.thefreelibrary.com [cached]

Dr. Bruce Weintraub, President of Trophogen commented, "It is very gratifying for Trophogen to partner with Bioniche, a world renowned leader in veterinary reproduction, to develop its recombinant superagonist technology for this market."


Bioniche

www.bioniche.com [cached]

Dr. Bruce Weintraub, President of Trophogen commented, "It is very gratifying for Trophogen to partner with Bioniche, a world renowned leader in veterinary reproduction, to develop its recombinant superagonist technology for this market."


Dr. Bruce Weintraub, ...

bioniche.com [cached]

Dr. Bruce Weintraub, President of Trophogen commented, "It is very gratifying for Trophogen to partner with Bioniche, a world renowned leader in veterinary reproduction, to develop its recombinant superagonist technology for this market."

Similar Profiles

Other People with this Name

Other people with the name Weintraub

Jeff Weintraub
Fisher & Phillips LLP

Josh Weintraub
ABC Pest

Daniel Weintraub
Audax Group, Limited Partnership

Yis Weintraub
SwissCham Beijing

Peter Weintraub
FIDF

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory